April 2, 2026 11:48 AM
Latest:
  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness
  • Equinox Ups Its Offer For Calibre: Investors Said No!
  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
  • Agnico Eagle Q1 Earnings: Costs Go Down?!
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Cannabis
    • Commentary
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Resources
    • Technology
  • Resources
  • Energy
  • Technology
  • Coverage Companies
    • Brazil Potash
    • Canadian Copper
    • Cardiol Therapeutics
    • Cytophage Technologies
    • ESGold Corp
    • First Majestic Silver
    • Golden Cariboo Resources
    • Nations Royalty Corp
    • Plurilock Security
    • Power Metallic
    • PTX Metals
    • Riverside Resources
    • Rua Gold
    • Silver47 Exploration
    • Sonoro Gold
    • Spirit Blockchain
    • Temas Resources
  • Verses AI
  • About
  • Contact Us

Psychedelics

Latest Psychedelics 

Numinus Sells Utah Clinics For US$3.53 Million

November 15, 2024 8:03 AMNovember 15, 2024 8:03 AM Jay Lutz 0 Comments Numinus Wellness Inc

Numinus Wellness (TSX: NUMI) is disposing of its US-based clinics in a transaction that is said to create an “asset-light

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Numinus Wellness Walks From Acquisition Of MedBright AI

August 12, 2024 10:08 AMAugust 12, 2024 10:08 AM Jay Lutz 0 Comments MedBright AI, Numinus Wellness Inc

Numinus Wellness (TSX: NUMI) has walked away from a plan to add artificial intelligence assets to its portfolio. The firm

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Numinus Wellness To Acquire MedBright AI In Bid To Add Artificial Intelligence To Portfolio

June 20, 2024 9:41 AMJune 20, 2024 9:41 AM Jay Lutz 0 Comments MedBright AI, Numinus Wellness Inc

Numinus Wellness (TSX: NUMI) is set to get into the artificial intelligence business. The firm this morning announced that it

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Red Light Holland To Consult PharmAla On Developing Medical Psilocybin

February 9, 2024 8:50 AMFebruary 9, 2024 8:50 AM Jay Lutz 0 Comments PharmAla Biotech, Red Light Holland

Red Light Holland (CSE: TRIP) is making moves to enter the clinical side of psilocybin, announcing this morning that it

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics SPACs 

Filament Health Walks Away From SPAC Merger, US$14.4 Million Financing

December 20, 2023 9:14 AMDecember 20, 2023 9:14 AM Jay Lutz 0 Comments Filament Health

Filament Health (NEO: FH) is walking away from a Nasdaq listing and major financing after hitting certain roadblocks related to

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Cybin Rallies After Steve Cohen’s Point 72 Disclosed 8.1% Equity Purchase

September 19, 2023 3:42 PMSeptember 19, 2023 1:36 PM ER Velasco 0 Comments Cybin, Point 72, Steve Cohen

Renowned hedge fund manager and Wall Street mogul Steve Cohen is showing his confidence in the psychedelic sector. Cohen’s hedge

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Filament Health To Merge With SPAC To Obtain Nasdaq Listing

July 19, 2023 9:33 AMJuly 19, 2023 9:33 AM Jay Lutz 0 Comments Filament Health

Filament Health (NEO: FH) is claiming that shareholders are about to receive US$0.85 per share in value following an agreement

Share
Tweet
Share
Reddit
Read more
Latest Politics Psychedelics 

Snowfall at the White House: Cocaine Found on White House Grounds Sparks Evacuation, Secret Service Investigation

July 4, 2023 2:41 PMJuly 4, 2023 3:53 PM Hermina Paull 0 Comments Cocaine, Hunter Biden, White House

The White House and its surroundings were temporarily evacuated on Sunday following the discovery of an unknown substance on the

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

FDA Releases Guidance for Psychedelic Drug Trials With Possibility of Removing Schedule I Classification

June 27, 2023 3:03 PMJune 27, 2023 10:38 AM ER Velasco 0 Comments FDA, Psychedelics

The U.S. Food and Drug Administration (FDA) has released a groundbreaking draft guidance to provide crucial insights for researchers exploring

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics Video Series 

Psyched Wellness Attracts Major Investment

June 9, 2023 1:30 PMJune 9, 2023 11:57 AM Jay Lutz 0 Comments Jeff Stevens, Psyched Wellness, The Daily Dive

Jeffrey Stevens, CEO & Director of Psyched Wellness (CSE: PSYC) joins us in today’s episode of the Daily Dive. Jeff

Share
Tweet
Share
Reddit
Read more
  • ← Previous

Latest

  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness

  • Equinox Ups Its Offer For Calibre: Investors Said No!

  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash

  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win

  • Agnico Eagle Q1 Earnings: Costs Go Down?!

  • Why Gold Is Secretly Flooding Into The U.S. & Who’s Suppressing Silver?! | Andy Schectman

  • Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen – ESGOLD Corp.

  • Canada Is Nearly Last In Growth Among OECD Countries

Video

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Full Analysis Latest Resources Video Series 

Teck Resources Q1 Earnings: Defying Copper Industry Weakness

April 27, 2025 4:40 PM Jay Lutz 0

Yesterday in our coverage of First Quantum Mining’s business we said it was a terrible time to be a copper

Trending

  • Did Trump Also Freeze the US International Development Finance Corp? 
  • Lynx Air Files For Creditor Protection, Operations To Cease Monday
  • Beyond Meat Rallies 21% Despite Missing Estimates In Q2 2022, Announcing Job Cuts
  • MJardin: A Bridging Finance Debt Warehouse
  • The Golden Triangle: British Columbia’s Exploration Hotbed

News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
Biotech Latest News 

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek
Latest News Resources 

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0
Canadian Copper To Begin Exploration At Murray Brook East
Latest News Resources 

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Bonds
  • Cannabis
  • Commentary
  • Crypto
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2026 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.